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In Brief
Mutations in Munc18-1, an essential
component of the machinery controlling
neurotransmission, are linked to the
development of early infantile epileptic
encephalopathy (EIEE). In this study,Mar-
tin et al. show that one of thesemutations,
C180Y, results in a thermolabile protein
with a strong propensity to aggregate.
The level of Munc18-1C180Y is regulated
by K48-linked polyubiquitination and pro-
teasomal degradation. The impaired exo-
cytic function of Munc18-1C180Y is
rescued by growth at a permissive tem-
perature. An imbalance in exocytosis
could therefore underpin EIEE.
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Munc18-1 is a critical component of the coremachin-
ery controlling neuroexocytosis. Recently, mutations
in Munc18-1 leading to the development of early
infantile epileptic encephalopathy have been discov-
ered. However, which degradative pathway controls
Munc18-1 levels and how it impacts on neuroexocy-
tosis in this pathology is unknown. Using neurose-
cretory cells deficient in Munc18, we show that a
disease-linked mutation, C180Y, renders the protein
unstable at 37C. Although the mutated protein re-
tains its function as t-SNARE chaperone, neuroexo-
cytosis is impaired, a defect that can be rescued at
a lower permissive temperature. We reveal that
Munc18-1 undergoes K48-linked polyubiquitination,
which is highly increased by the mutation, leading
to proteasomal, but not lysosomal, degradation.
Our data demonstrate that functional Munc18-1
levels are controlled through polyubiquitination and
proteasomal degradation. The C180Y disease-
causing mutation greatly potentiates this degrada-
tive pathway, renderingMunc18-1 unable to facilitate
neuroexocytosis, a phenotype that is reversed at a
permissive temperature.INTRODUCTION
Neurotransmission is underpinned by the regulated fusion of
synaptic vesicles with the plasma membrane in a process cata-
lyzed by soluble N-ethylmaleimide-sensitive factor-attachment
protein receptors (SNARE) proteins (Weber et al., 1998; Chen
and Scheller, 2001). The fusion reaction is controlled by a large
number of regulatory proteins (Su¨dhof and Rizo, 2011; Jahn
and Fasshauer, 2012), one of the most critical of which is
the Sec1/Munc18 family protein, Munc18-1 (Toonen and Ve-
rhage, 2007; Han et al., 2010). Knockout of Munc18-1 in mice
leads to perinatal paralysis-induced lethality, demonstrating
the essential nature of this protein in neurotransmission (Verhage206 Cell Reports 9, 206–218, October 9, 2014 ª2014 The Authorset al., 2000). Munc18-1 plays several roles in neuroexocytosis,
as different conformations and complexes of the protein regulate
the transport of the t-SNARE syntaxin 1a (Sx1a) to the plasma
membrane, as well as the membrane fusion reaction itself (re-
viewed in Toonen and Verhage, 2007 and Han et al., 2010).
Disruption of either of these functions prevents SNARE-medi-
ated membrane fusion (Martin et al., 2013; Han et al., 2013).
Depletion of Munc18-1 reduces the docking of secretory gran-
ules, lowers Sx1a protein levels, and leads to a mislocalization
of residual Sx1a to intracellular compartments (Verhage et al.,
2000; Voets et al., 2001; Arunachalam et al., 2008; McEwen
and Kaplan, 2008; Han et al., 2009; Malintan et al., 2009; Papa-
dopulos et al., 2013; Martin et al., 2013).
An additional level of regulation that could significantly impact
on neuroexocytosis is the control of Munc18-1 functional
expression. Although the mechanisms controlling the level of
the protein are currently unknown, recent studies have sug-
gested that mutations in Munc18-1 associated with the develop-
ment of a severe early infantile epileptic encephalopathy (EIEE)
(Deprez et al., 2010; Otsuka et al., 2010; Tavyev Asher and Sca-
glia, 2012; Barcia et al., 2014) result in a thermolabile protein with
reduced expression level (Saitsu et al., 2008, 2010). As one of the
characteristic features of EIEE is a pattern of ‘‘burst suppres-
sion’’ brain activity in electroencephalograms, where periods of
intense neurological activity are interspersedwith periods of pro-
found brain inactivity, one possible contributing factor could be
an imbalance in neurotransmission, due to reduced functional
levels of Munc18-1.
In this study, we set out to identify the mechanisms regulating
the levels of functional Munc18-1 and to analyze how a point
mutation, C180Y, directly linked to the development of EIEE,
affected this regulation. We show that Munc18-1 undergoes
K48-linked polyubiquitination, which directs its degradation
through the proteasomal system. Our results further show that
temperature-sensitive structural changes associated with the
C180Y mutation result in the generation of protein oligomers
and aggregates and potentiate its degradation through the pro-
teasome, leading to severely reduced functional Munc18-1
levels. Interestingly, the reduced Munc18-1 expression impairs
its function in membrane fusion, although sufficient Munc18-1
activity is retained in order tomediate its Sx1a chaperoneactivity.
Consistent with protein misfolding, a shift to a lower, permissive
Figure 1. Munc18-1C180Y Levels Are Reduced Relative toWild-Type but Can Be Recovered by Growth at a Permissive Temperature with the
Concomitant Rescue of Sx1a
(A and B) Munc18-1 in a complex with the soluble region of closed Sx1a as solved by X-ray crystallography (Burkhardt et al., 2008). (A) The Cys180 > Tyr mutation
is located within domain 2 of Munc18-1, as indicated by red spheres, with no direct interaction with Sx1a (blue). (B) Close-up stereoexamination shows that
Cys180 is buried within a highly hydrophobic region of the Munc18-1 protein.
(C–G) DKD-PC12 cells were transfected with control vector, Munc18-1wild-type (wt)-emGFP, orMunc18-1C180Y-emGFP for 48 hr, prior to incubation at 37Cor
32C for 24 hr. (C) Cells incubated at 37Cwere fixed, immunolabeled for the Golgi marker GM130, and the nuclei stained using DAPI. emGFP was imaged under
identical conditions for cytosolic labeling (i and ii) or at low laser intensity for aggresomes (iii). The scale bar represents 5mm. (D) Cells were fixed and the nuclei
(legend continued on next page)
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temperature fully restores the function ofMunc18-1 inmembrane
fusion. Our results suggest that the C180Y mutation could
generate large cellular aggregates, leading to an imbalance in
neurotransmission in key areas of the brain at physiological tem-
perature, by reducing the level of functional activity required to
support SNARE-mediated membrane neuroexocytosis.
RESULTS
An EIEE-Linked Mutant of Munc18-1 Is Stabilized at
Permissive Temperature, Supports the Transport of
Sx1a to the Plasma Membrane in DKD-PC12 Cells,
and Binds Normally to Sx1a In Vitro
Several mutations in Munc18-1 have been directly linked to
the development of EIEE (Saitsu et al., 2008, 2010; Mignot
et al., 2011). We conducted a detailed analysis of the
function and regulation of one of these mutations, a Cys >
Tyr point mutation (C180Y), buried in the hydrophobic core of
Munc18-1 domain 2 (Figures 1A and 1B). As Munc18-1C180Y
exhibits a melting temperature very close to normal physiolog-
ical temperature compared to wild-type Munc18-1 (Munc18-
1WT) (Saitsu et al., 2008), we considered whether Munc18-
1C180Y could encode for a temperature-sensitive mutation.
To examine this further, we attempted to rescue Munc18-
1C180Y-emerald GFP (emGFP) expression levels in PC12 cells
engineered to knock down Munc18-1 and Munc18-2 (DKD-
PC12) by reducing the growth temperature to the more-permis-
sive 32C.
DKD-PC12 cells were transfected with Munc18-1WT-emGFP
or Munc18-1C180Y-emGFP and incubated for 48 hr at 37C.
Each transfection was subsequently split and incubated at either
37C or 32C for a further 24 hr prior to fixation and processing
for immunofluorescence microscopy (Figures 1C and 1D) or
preparation of whole-cell lysates for immunoblotting (Figures
1E–1G). Consistent with previous reports (Saitsu et al., 2010),
we found that, following transient transfection, Munc18-
1C180Y had a significantly reduced expression level relative to
the wild-type protein, which could be detected as both a
decrease in total protein expression (Figure 1E) and reduced
emGFP fluorescence by confocal microscopy (Figure 1C). To
examine this further, we first quantified the proportion of cells
showing detectable emGFP fluorescence (Figure 1D). We found
that, following growth at 37C, there were significantly fewer
cells expressing detectable levels of Munc18-1C180Y-emGFP
than Munc18-1WT-emGFP. Lowering the growth temperature
to 32C for 24 hr resulted in a significant increase in the number
of cells with detectable Munc18-1C180Y-emGFP fluorescence.
In addition, we also noted significant differences in the distribu-
tion of this fluorescence. Although both Munc18-1WT-emGFP
and Munc18-1C180Y-emGFP were predominantly detected in
the cytosol (Figure 1C), a subset of cells (20%; also see Fig-
ure 5F) also contained Munc18-1C180Y-emGFP in large, fluo-
rescent aggregates that localized to the juxtanuclear region,stained using DAPI. The number of cells containing detectable emGFP fluoresce
results showmean ± SEM (n = 3). (E–G) Transfected cells were analyzed by weste
and Sx1a was quantified relative to b-actin. *p < 0.05; **p < 0.01; ***p < 0.001; re
See also Figure S1.
208 Cell Reports 9, 206–218, October 9, 2014 ª2014 The Authorsdirectly adjacent to the Golgi complex (Figure 1C). Identical phe-
notypes were observed when Munc18-1C180Y-emGFP was
expressed in wild-type PC12 cells, or was expressed at 32C,
confirming that this phenotype was intrinsic to the mutation itself
and in good agreement with the reported lower expression of
Munc18-1C180Y in N2a cells (Saitsu et al., 2010).
One of the key features observed in Munc18-depleted
DKD-PC12 cells is a concomitant reduction in the level of Sx1a
protein (Figure S1; Verhage et al., 2000; Arunachalam et al.,
2008; McEwen and Kaplan, 2008; Han et al., 2009). We therefore
tested whether reducing the growth temperature could rescue
the expression levels of both expressed Munc18-1 (Figure 1F)
and endogenous Sx1a (Figure 1G). Consistent with previous
studies, endogenous Sx1a expression was significantly rescued
in DKD-PC12 cells following the re-expression of Munc18-1WT.
However, no detectable rescue was observed upon Munc18-
1C180Y expression. In contrast, when the cells were incubated
at 32C for 24 hr prior to analysis, there was a significant
increase in the level of both Sx1a and Munc18-1C80Y-emGFP
compared to growth at 37C (Figures 1F and 1G). In fact, both
Munc18-1C180Y and Sx1a were recovered at 32C to levels
indistinguishable from those obtained following expression of
wild-type Munc18-1. The temperature-dependent rescue of
expressed Munc18-1 and endogenous Sx1a suggests that
Munc18-1C180Y retained the ability to chaperone Sx1a, a key
feature requiring intact Sx1a binding.
We therefore examined the direct interaction between
Munc18-1C180Y and Sx1a in vitro using purified proteins.
Importantly, whereas we noted that the yield of bacterially pro-
duced recombinant Munc18-1C180Y was much lower than
that of the wild-type protein, suggesting problems with protein
folding and/or stability, the thermodynamic properties of
Munc18-1C180Y binding to Sx1a were indistinguishable from
that of wild-type as measured by isothermal titration calo-
rimetry (Figure 2A; Table 1). Similarly, a proximity-based assay
(ALPHAScreen) analysis using in vitro translated proteins (Sier-
ecki et al., 2013, 2014; Gambin et al., 2014) could detect no
difference in Sx1a binding between Munc18-1WT or Munc18-
1C180Y proteins (Figures 2B–2D). Together, these data confirm
that Munc18-1C180Y is able to form a binary complex with Sx1a
in vitro, as suggested previously (Saitsu et al., 2008).
As the binary interaction between Munc18-1 and Sx1a is
required to mediate the transport of Sx1a to the cell surface,
we analyzed whether the chaperone function of Munc18-1
was affected by the mutation and temperature in DKD-PC12
cells. In control empty-vector-transfected or untransfected
DKD-PC12 cells, a low level of endogenous Sx1a labeling
was detected in intracellular compartments (Figures 2E–2G).
In contrast, following re-expression of either Munc18-1WT-
emGFP or Munc18-1C180Y-emGFP, Sx1a was predominantly
present at the cell surface. Quantification of Sx1a labeling at
the cell surface revealed that Munc18-1WT-emGFP and
Munc18-1C180Y-emGFP were both capable of rescuing Sx1ance was quantified under identical imaging conditions. *p < 0.05; **p < 0.01;
rn blotting and the amount of Munc18-1wt-emGFP, Munc18-1C180Y-emGFP,
sults show mean ± SEM (n = 3).
(legend on next page)
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Table 1. Thermodynamic Parameters for the Binding of Sx1a2-243 to Munc18-1WT Determined by Isothermal Titration Calorimetry
Protein Interaction DH (kCal mol1) TDS (kCal mol1) DG (kCal mol1) Kd (nM) n
Munc18-1WT: Sx1a2-243 22.5 ± 0.67 11.9 ± 0.66 10.5 ± 0.34 19.1 ± 1.14 0.91 ± 0.03
Munc18-1C180Y: Sx1a2-243 23.7 ± 0.89 13.1 ± 0.95 10.6 ± 0.66 18.6 ± 1.71 1.02 ± 0.01
Values are expressed as mean ± SEM (n = 5). All experiments were performed at 298 K.plasma membrane localization to the same degree (Figure 2G).
Importantly, Sx1 transport was not affected by growth at
different temperatures. The presence of Munc18-1C180Y-
emGFP aggregates did not preclude the transport of Sx1a to
the cell surface. These data confirm that Munc18-1C180Y is
capable of binding to Sx1a in a binary complex and can rescue
its transport to the cell surface in DKD-PC12 cells.
Munc18-1C180Y Is Unable to Rescue Stimulated
Exocytosis at 37C but Regains Full Functionality
at 32C
Our findings demonstrate that Munc18-1C180Y is capable of
binding to Sx1a and transporting it to the cell surface. However,
as previous studies had shown that Munc18-1C180Y has
reduced binding to a mutant of Sx1a mimicking an ‘‘open’’
conformation primed for SNARE complex interactions (Saitsu
et al., 2008), we directly analyzed its ability to rescue neuroexo-
cytosis in DKD-PC12 cells. emGFP-tagged Munc18-1WT or
Munc18-1C180Y was re-expressed in DKD-PC12 cells together
with NPY-mCherry. The fusion of individual secretory granules
containing NPY-mCherry with the cell surface was analyzed by
total internal reflectance fluorescence (TIRF) microscopy, before
and during stimulation (Figures 3A–3C). Whereas no fusion of
secretory granules was detected in unstimulated cells under
any condition, we found that Munc18-1WT expression restored
stimulated secretory granule fusion in DKD-PC12 cells as previ-
ously described (Martin et al., 2013), regardless of growth tem-
perature (Figures 3A–3D). In contrast, Munc18-1C180Y did not
rescue secretory granule fusion at 37C, but full restoration of
neuroexocytosis was achieved when cells were incubated at
32C for 24–48 hr prior to analysis (Figure 3D). The inability of
Munc18-1C180Y to restore stimulated secretory granule fusion
at 37C did not result from a defect in secretory granule biogen-
esis, as there was no significant difference in the number ofFigure 2. Munc18-1C180Y Binds to Sx1a and Supports Its Transport to
(A) Isothermal titration calorimetry of Munc18-1wt (triangles) and Munc18-1C180
soluble region lacking the C-terminal transmembrane helix, which predominantly
(B) Schematic representation of the ALPHAScreen proximity assay. The streptavi
tagged proteins. The acceptor bead coated with anti-myc binds to myc-tagged
680 nm, which has a half-life of 4 ms and can diffuse 200 nm in solution. If an ac
bead and luminescence is observed at 520–620 nm. Protein:protein interactions
(C) ALPHAScreen assay binding of Munc18-1WT and Munc18-1C180Y to Sx1a. R
units.
(D) Typical ALPHAScreen data obtained for a LTE-expressed noninteracting prote
test pairs (GFP-Sx1a:Munc18-1WT-Cherry-myc [WT] or GFP-Sx1a:Munc18-1-C1
(n = 5).
(E and F) DKD-PC12 cells were transfected with control vector, Munc18-1wt-emG
for 24 hr. Cells were fixed and labeled for Sx1a. Asterisks indicate transfected ce
(G) Labeling of Sx1a at the plasma membrane, shown in (E) and (F), was quantifie
*p < 0.05; **p < 0.01; results show mean ± SEM (n = 3).
See also Figure S2.
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NPY-mCherry-containing secretory granules or following label-
ing for the secretory granule marker protein, synaptotagmin-1
(Figures 3E–3G). As these data suggest that the function of
Munc18-1C180Y could be restored at permissive temperature,
we further analyzed the ability of this mutant to rescue stimulated
secretion using a biochemical assay. Munc18-1WT-emGFP or
Munc18-1C180Y-emGFP was re-expressed in DKD-PC12 cells
together with NPY-human placental alkaline phosphatase
(hPLAP) (Martin et al., 2013; Tomatis et al., 2013; Figures 3E–
3G). When the cells were incubated at 32C for 24 hr prior to
assaying, both Munc18-1WT-emGFP and Munc18-1C180Y-
emGFP were able to rescue stimulated NPY release to the
same extent (Figure 3H). However, following re-expression of
Munc18-1C180Y at 37C, the release of NPY-hPLAP was signif-
icantly reduced (Figure 3H). Together, these data confirm that
the C180Y mutation is responsible for the temperature-depen-
dent defect in stimulated secretion.
Munc18-1C180Y Forms Temperature-Dependent,
Detergent-Insoluble Cytosolic Protein Aggregates in
PC12 Cells and In Vitro
The data described above suggest that Munc18-1C180Y is a
thermolabile protein that can function normally if its effective
levels are increased by reducing growth temperature. We there-
fore further examined causes leading to the two observed phe-
notypes of Munc18-1C180Y: reduced cytosolic expression
levels and increased aggregation.
To examine the nature of the fluorescent Munc18-1C180Y-
emGFP aggregates in more detail, we used correlative light and
electron microscopy. PC12 cells were transfected with either
Munc18-1WT-emGFP or Munc18-1C180Y-emGFP, and fluo-
rescent cells were identified and analyzed by transmission elec-
tron microscopy. In Munc18-1C180Y-emGFP-expressing cells,the Cell Surface
Y (squares) binding to Sx1a (2–243). These Sx1a residues constitute the Sx1a
exists in a closed conformation.
din-coated donor bead binds biotin-coupled GFP-nanotrap that recruits GFP-
proteins. The donor bead releases singlet oxygen (1O2) upon illumination at
ceptor bead is within that distance, 1O2 reacts with derivatives in the acceptor
result in a close proximity, leading to the ALPHAScreen signal.
esults equal average binding index ± SEM (nR 3 experiments). A.U., arbitrary
in pair (control, GFP-Munc18-1WT andMunc18-1WT-Cherry-myc) and for two
80Y-Cherry-myc [C180Y]) over a range of dilutions. Results showmean ± SEM
FP, or Munc18-1C180Y-emGFP for 48 hr, prior to incubation at 37C or 32C
lls. The scale bar represents 5 mm.
d and the level relative to control vector-transfected cells at 37C determined.
Figure 3. Munc18-1C180Y Fails to Support
Full Stimulated Membrane Fusion at 37C,
a Phenotype that Can Be Rescued by
Growth at 32C
(A–D) DKD-PC12 cells were cotransfected with
emGFP-tagged Munc18-1wt or Munc18-1C180Y
and NPY-mCherry for 48 hr, prior to incubation at
37Cor32C for24–48hr. (A)NPY-mCherry-labeled
secretory granules in the TIRF plane of a DKD-PC12
cell coexpressing Munc18-1wt-emGFP and incu-
bated at 37C. Enlargements (B) show a sequential
0.2s timeseriescontaininga fusionevent (redarrow)
following 2 mM Ba2+ stimulation. The graph (C)
shows the spike in fluorescence intensity observed
as the secretory granule approaches the plasma
membrane during the fusion event. The scale bar
represents 5 mm. (D) Secretory granule fusion was
imaged at 10 Hz by TIRF microscopy for 5 min
following 2 mM Ba2+ stimulation at either 37C or
32C as indicated and individual fusion events
quantified relative to the surface area. **p < 0.01;
results show mean ± SEM (n = 5 independent
experiments; 2 to 3 cells/experiment).
(E–G) DKD-PC12 cells were transfected with
empty vector (control), Munc18-1wt-emGFP, or
Munc18-1C180Y-emGFP with or without NPY-
mCherry, fixed, and processed for TIRF micro-
scopy. Cells expressing Munc18-1 constructs
alone were immunolabeled for synaptotagmin-1
(Syt1). (E) The number of secretory granules (SGs)
labeledwith either Syt1 (total SGs) orNPY-mCherry
within the TIRF plane of unstimulated cells was
quantified; results show mean ± SEM (n = 5 inde-
pendent experiments for NPY-mCherry; n = 3 in-
dependent experiments; 5–10 cells/experiment
for Syt1). Representative TIRF images of NPY-
mCherry-labeled secretory granules (F) or Syt1-
labeled secretory granules (G) in unstimulated
DKD-PC12 cells. The scale bar represents 5 mm.
(H) DKD-PC12 cells were cotransfected with
emGFP-tagged Munc18-1, Munc18-1C180Y, or
empty vector and NPY-hPLAP and incubated at
37C or 32C for 24 hr prior to measuring K+-
stimulated secretion over 15 min. Results show
mean ± SEM. n = 3. **p < 0.01; ***p < 0.001; ****p <
0.0001. ns, not significant.fluorescence was clearly correlated with the presence of exten-
sive, electron-dense protein aggregates in the cytoplasm of the
cells and clustering toward the cell nucleus (Figure 4A). The pro-
tein aggregates were not membrane bound and showed no pref-
erential association with other organelles, including secretory
granules. Consistent with the immunofluorescence microscopy
shown in Figure 3, there was also no effect of Munc18-1C180Y
expressionon thenumberordockingof secretorygranules incells
containing large protein aggregates (Figure 4B and 4C). The
extent of the aggregate accumulation varied between cells, with
some cells showing a high abundance of aggregates whereasCell Reports 9, 206–21other cells had low or undetectable aggre-
gation. No protein aggregates were de-
tected in control, untransfected cells, or
in cells expressing Munc18-1WT-emGFP.To determine the biochemical nature of the Munc18-1C180Y
aggregates, we analyzed their solubility in denaturing (SDS)
and nondenaturing (Triton X-100) detergents. We found that
Munc18-1C180Y was highly resistant to solubilization in
1% Triton X-100, with less than 10% recovered relative to
the whole-cell lysate (Figures 4D and 4E). This low percentage
of recoverable Munc18-1C180Y was surprising, as confocal
microscopy had shown that only a small percentage of
the Munc18-1C180Y-transfected cells contained detectable
fluorescent aggregates. This suggests that Munc18-1C180Y
may also be present in much-smaller, detergent-insoluble8, October 9, 2014 ª2014 The Authors 211
(legend on next page)
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oligomers in the cytosol, below the resolution limit of light
microscopy.
To examine the process leading to Munc18-1C180Y aggrega-
tion, we used single-molecule fluorescence spectroscopy to
directly assess protein oligomerization of in vitro synthesized
proteins (Figures 4F–4I; Gambin et al., 2014). Fluorescently
tagged Munc18-1WT and Munc18-1C180Y were expressed
in a eukaryotic-cell-free system (Figure S2A), and the fluores-
cence intensity of single, freely diffusing molecules in a defined
confocal volume was measured (Figure 4F). To determine the
effect of temperature, cell-free extracts were incubated between
30C and 40C for 30 min prior to imaging and time traces
analyzed for the presence of aggregates by determining the dis-
tribution of values around the average fluorescence (Figures 4G
and S2B). In the case of folded monomeric Munc18-1, the vari-
ations in the intensity as monomers entered and left the focal
volume were small. When aggregates were present, the bright
particles created large fluctuations of intensity (Figure 4H). By
calculating the distribution of intensity values and measuring
their SD, we were able to measure protein aggregation. As
shown in Figure 4G, this parameter remained low for Munc18-
1WT but increased significantly with increasing temperature
for Munc18-1C180Y. Individual time traces for Munc18-
1C180Y incubated at either 32C or 37C clearly showed the
increasing propensity to form aggregates at 37C (Figure 4H).
Munc18-1C180Y Is K48 Polyubiquitinated and
Degraded by the Proteasome, and Aggregated Protein
Rapidly Accumulates near the Microtubule-Organizing
Center following Proteasome Inhibition
Protein aggregation is often considered a protective response
to the presence of misfolded proteins in the cytosol. Although
protein aggregates themselves are often degraded by the
lysosomal system through incorporation into autophagosomes
(Knaevelsrud and Simonsen, 2010; Yamamoto and Simonsen,
2011), another efficient mechanism to dispose of misfolded
proteins is the 26S proteasome (Wickner et al., 1999). To deter-
mine the mechanism underpinning Munc18-1C180Y degrada-
tion, PC12 cells were transfected with either Munc18-1WT-
emGFP or Munc18-1C180Y-emGFP and incubated withFigure 4. Munc18-1C180Y Is Detergent Insoluble and Forms Cytosolic
(A) PC12 cells were transfected with Munc18-1C180Y-emGFP, fixed, and proc
1C180Y-emGFP fluorescence were found to contain varying amounts of electron-
endoplasmic reticulum; mt, mitochondria; sg, secretory granules (also marked w
(B and C) The high levels of aggregated protein in theMunc18-1C180Y-emGFP tra
relative to Munc18-1wt-emGFP-expressing cells; results show mean ± SEM (n =
(D) PC12 cells were transfected withMunc18-1wt-emGFP orMunc18-1C180Y-em
1% SDS, and samples were analyzed by SDS-PAGE and western blotting for M
(E) The level of protein expression shown in (D) was quantified relative to b-actin an
SEM (n = 3).
(F) Munc18-1 brightness analysis principle: GFP-tagged, LTE-expressed Munc
diffuse freely in solution. Fluorescent proteins were detected upon entry in the
aperture microscope objective.
(G) Aggregation of Munc18-1wt and Munc18-1C180Y as a function of tempera
expressed in LTE for 2 hr before being incubated at between 30C and 40C for
width of the photon distribution was used as a measure of aggregation propens
(H and I) Representative fluorescence time traces for single, freely diffusing Munc
function of time. (H) Aggregates were clearly detected in Munc18-1C180Y-GFP
See also Figure S3.proteasome (MG132) or lysosome (NH4Cl or bafilomycin A1)
inhibitors (Figures 5A–5C). Consistent with the majority of
Munc18-1C180Y being degraded by the proteasome, we
observed a significant increase in the level of Munc18-
1C180Y in the presence of the proteasomal, but not the
lysosomal, inhibitors. No significant increase in the level of
Munc18-1WT-emGFP was observed.
To examine the effect of proteasome inhibition on the distribu-
tion of mutated Munc18-1, PC12 cells were transfected with
Munc18-1WT-emGFP or Munc18-1C180Y-emGFP and treated
with or without 2.5 mM MG132 up to 4 hr prior to fixation for
immunofluorescence microscopy. Although this treatment had
no effect on the distribution of Munc18-1WT-emGFP, there
was a significant redistribution of Munc18-1C180Y-emGFP
from a diffuse, predominantly cytosolic distribution, to an intense
concentration in the dispersed microaggregates and/or into two
bright aggregates at the perinuclear region of the cell (Figures 5D
and 5E). Interestingly, the appearance of the perinuclear aggre-
gates preceded the appearance of dispersed microaggregates
by several hours, suggesting the presence of preexisting aggre-
gated material. The proportion of cells containing either large
perinuclear aggresomes or large dispersed aggregates was
unchanged (Figure 5F). Colabeling with g-tubulin, a marker of
the microtubule-organizing center, confirmed that Munc18-
1C180Y was predominantly accumulating in this region of the
cell (Figure 5G). This distribution is consistent with Munc18-
1C180Y in the periphery being associated with small aggre-
somes, which undergo microtubule-based translocation toward
the proteasome (Wiese and Zheng, 2006).
Degradation of proteins by the proteasome is encoded by
polyubiquitination following the attachment of K48-linked polyu-
biquitin chains (Komander and Rape, 2012). We therefore inves-
tigated the ubiquitination status of Munc18-1WT-emGFP and
Munc18-1C180Y-emGFP, both in control cells and following in-
hibition of the proteasome for up to 24 hr (Figures 6A and 6B).
Consistent with previous data (Figure 5A), Munc18-1C180Y
showed a significant increase in expression after inhibition of
the proteasome for 8 hr that was further increased after 24 hr
(Figures 6A and 6B). Concomitantly, there was a decrease in
the proportion of Triton-X-100-soluble Munc18-1C180Y and anAggregates
essed for correlative light and electron microscopy. Cells with high-Munc18-
dense, cytosolic protein aggregates that were not observed in control cells. er,
ith arrowheads).
nsfected cells did not affect either the number or docking of secretory granules
15–20 cells per condition).
GFP.Whole-cell lysates (WCL) were extracted with 1%Triton X-100 (TX100) or
unc18-1 and b-actin.
d normalized to the whole-cell lysate samples. **p < 0.01; results showmean ±
18-1wt or Munc18-1C180Y was diluted to nM concentration and allowed to
confocal volume created by a 488 nm laser focused by a 403/1.2 numerical
ture. Munc18-1wt (gray squares) and Munc18-1C180Y (red diamonds) were
15 min. Samples were then diluted and subjected to brightness analysis. The
ity with increasing temperature.
18-1C180Y molecules. The fluorescence intensity (photons/ms) is plotted as a
samples incubated at 37C for 30 min.
Cell Reports 9, 206–218, October 9, 2014 ª2014 The Authors 213
Figure 5. Proteasome Inhibition Leads to Munc18-1C180Y Aggregation at the Microtubule-Organizing Center
(A) PC12 cells transfectedwithMunc18-1wt-emGFP orMunc18-1C180Y-emGFPwere cultured for 24 hr before being treated singly or in combination with 2.5 mM
MG132, 25 mM NH4Cl, 200 nM Bafilomycin A1 (Baf A1), or vehicle (control) for 24 hr. Samples were analyzed by western blotting for Munc18-1 and b-actin.
(B and C) The level of protein expression as shown in (A) was analyzed relative to b-actin and normalized to control untreated samples. *p < 0.05; **p < 0.001;
results show mean ± SEM (n = 3).
(D–F) PC12 cells transfected with Munc18-1wt-emGFP or Munc18-1C180Y-emGFP were cultured for 48 hr prior to addition of 2.5 mM MG132 or an equivalent
volume of DMSO (control) for various times up to 4 hr. Cells were fixed and stained for DAPI. The scale bar represents 5 mm. (D) Five distinct distributions of
(legend continued on next page)
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Figure 6. Ubiquitination of Aggregated
Munc18-1C180Y
(A–C) PC12 cells were transfected with control
vector, Munc18-1wt-emGFP, or Munc18-1C180Y-
emGFP and cultured for 48 hr prior to addition of
2.5 mM MG132 or an equivalent volume of
DMSO for 8 hr or 24 hr. (A) Cells were extracted
with 1% Triton X-100 (TX100) or 1% SDS and
analyzed by SDS-PAGE and western blotting for
Munc18-1 and b-actin. (B) The level of protein
expression shown in (A) was quantified relative
to b-actin and normalized to starting levels
(time 0). High-molecular-weight (MW) Munc18-1
was quantified from the fluorescent signal between
130 and 250 kD. *p < 0.05; **p < 0.01; ***p < 0.001;
results show mean ± SEM (n = 3) relative to
time 0. (C) Immunoprecipitation using GFP-nano-
trap demonstrated increased K48-linked poly-
ubiquitination of Munc18-1C180Y-emGFP under
control conditions, which was highly augmented
by inhibition of the proteasome.
(D and E) PC12 cells were transfected with con-
trol vector, Munc18-1wt-emGFP, or Munc18-
1C180Y-emGFP for 24 hr prior to incubation at
37C or 32C for 72 hr. (D) Whole-cell lysates were
extracted with 1% Triton X-100 (TX100) or 1%
SDS, and samples were analyzed by SDS-PAGE
and western blotting for Munc18-1 and b-actin. (E)
Munc18-1C180Y-emGFP was also immunopre-
cipitated from SDS or Triton X-100 extracts of
whole-cell lysates (highlighted fractions in D) using
GFP-nanotrap and immunoblotted for Munc18-1,
ubiquitin, and K-48-linked polyubiquitin.increase in the presence of high-molecular-weight Munc18-
1C180Y species (Figures 6A and 6B). No change in the expres-
sion of Munc18-1WT was observed (Figure S3). The presence
of high-molecular-weight Munc18-1C180Y upon proteasome
inhibition was strongly suggestive of polyubiquitination. The
lysates were therefore subsequently analyzed for poly-
ubiquitination following solubilization in SDS to extract the ag-
gregates prior to immunoprecipitation using GFP-trap (Martin
et al., 2013). As predicted, and despite its low expression, we
found that Munc18-1C180Y was highly polyubiquitinated and
highly labeled for K48-linked polyubiquitin (Figure 6C). In
contrast, Munc18-1WT-emGFP showed no significant poly-
ubiquitination in control conditions (Figure 6C). Following inhibi-
tion of the proteasome, there was a significant increase in the
ubiquitination of both Munc18-1WT and Munc18-1C180Y.Munc18-1C180Y-emGFP were observed following proteasome inhibition (i–v). There was no change in the
relative proportion of cells with each distribution of Munc18-1C180Y-emGFP was quantified. *p < 0.05; **p
mean ± SEM (n = 3 independent experiments; 150–500 cells/expt).
(G) PC12 cells transfected with Munc18-1wt-emGFP or Munc18-1C180Y-emGFP were cultured for 48 hr prio
volume of DMSO (control) for 4 hr. Cells were fixed and labeled for g-tubulin. The scale bar represents 5 mm
Cell Reports 9, 206–21Together, these data confirm that
Munc18-1C180Y is not only unstable
and prone to misfolding but also
degraded by the proteasome system
following K48-linked polyubiquitination.Furthermore, the small increase in polyubiquitinated Munc18-
1WT following proteasome inhibition suggests that degradation
by the proteasome is a physiological component of the regula-
tion of Munc18-1 expression.
To investigate the relationship between polyubiquitination and
functional Munc18-1C180Y expression, we examined the distri-
bution of polyubiquitinated protein between the soluble and
the insoluble pools. Consistent with our previous data (Figure 1),
we were able to increase the amount of soluble Munc18-
1C180Y-emGFP by maintaining the cells at 32C for 72 hr
(Figure 6D). We subsequently immunoprecipitated Munc18-
1C180Y from the SDS-soluble and Triton-X-100-soluble frac-
tions and analyzed its ubiquitination. Interestingly, we found
that the soluble pool of Munc18-1C180Y showed significantly
reduced polyubiquitination relative to the insoluble pool atdistribution of Munc18-1wt-emGFP. (E and F) The
< 0.01; ***p < 0.001; ****p < 0.0001; results show
r to the addition of 2.5 mMMG132 or an equivalent
.
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permissive temperature (Figure 6E). These data show that the
C180Y mutation greatly accelerates polyubiquitination and pro-
teasomal degradation, leading to reduced Munc18-1 levels. Our
results also indicate that polyubiquitination is an important factor
regulating the expression level of Munc18-1WT.
DISCUSSION
In thecurrent study,weprovidedadetailedanalysis of theeffect of
anEIEE-linkedMunc18-1pointmutation (C180Y)on thedual func-
tion and cellular regulation of Munc18-1. Previous studies have
suggested that this mutation can directly affect binding to Sx1a
and that the protein has a propensity to form aggregates, consis-
tent with misfolding (Saitsu et al., 2008). We found that Munc18-
1C180Y is able to bind Sx1a with an equal efficiency to the
wild-type protein, restoring normal levels of Sx1a at the plasma
membrane. However, the correct folding of Munc18-1C180Y
in vitro is highly temperature-sensitive, resulting in elevated levels
of aggregation at temperatures above 32C. In neurosecretory
cells, Munc18-1C180Y is similarly unstable, forming detergent-
insoluble, cytosolic protein aggregates. The removal of misfolded
Munc18-1C180Y in cells is regulated by K48-linked poly-
ubiquitination and proteasomal degradation. The disease-associ-
ated variant is unable to facilitate stimulated exocytosis or to
stabilize Sx1a expression, suggesting the function of Munc18-
1C180Y in membrane fusion is impaired. Consistent with a
temperature-sensitive misfolding of Munc18-1C180Y, growth at
lower, permissive temperature fully restores its function in terms
of both Sx1a expression and membrane fusion.
Our data suggest that the C180Y mutation can induce a struc-
tural change in the protein that destabilizes normal protein
folding, potentiating its degradation through the proteasome.
This is completely consistent with the location of the Cys180
side chain, which is tightly buried within the hydrophobic core
of domain 2 (Figures 1A and 1B). Introduction of a bulky Tyr
side chain in this site will significantly perturb normal hydropho-
bic packing within this domain. Although this mutation can per-
turb protein folding, leading to protein aggregation, it is not
entirely clear why the Sx1a chaperone function remains normal
in cells expressing Munc18-1C180Y, whereas membrane fusion
and exocytosis are inhibited. Previous studies suggest that the
C180Y mutation can specifically interfere with the binding of
Sx1a in the open state, primed for SNARE complex formation,
but not in the closed state required for Sx1a trafficking (Saitsu
et al., 2008). Our data are consistent with this model, although
it is difficult to understand how this could occur mechanistically,
as the C180Y mutation in domain 2 is located distally from any
known Sx1a-binding sites (Figure 1A). An alternative explanation
for our data is that the mutation leads to lowered total levels of
functional Munc18-1 in the cell and that a greater level of
Munc18-1 is required to promote membrane fusion than is
necessary for stabilizing Sx1a levels at the cell surface. Further
work will be required to discriminate between these possibilities.
Mean core body temperature is tightly regulated and ranges
between 36.5C and 37.5C. Circular dichroism measurements
of purified, recombinant Munc18-1C180Y demonstrated that
the stability of the secondary structure was slightly reduced rela-
tive to the Munc18-1WT protein and further showed that the216 Cell Reports 9, 206–218, October 9, 2014 ª2014 The Authorsthermostability was lower, with a protein melting temperature
of 38.5C (Saitsu et al., 2008). Consistent with temperature-
sensitive misfolding, we have shown that the inability of
Munc18-1C180Y to facilitate membrane fusion manifest at
37C can be rescued by incubation at 32C. The existence of
temperature-sensitive mutations underlying the development
of different types of neurological disorders, including epilepsy
and febrile seizures, is not restricted toMunc18-1. Variousmuta-
tions in the voltage-gated sodium channel, SCN1A (Nav1.1),
associated with EIEE type 6, also known as Dravet syndrome
or severe myoclonic epilepsy of infancy, as well as with the
more benign pediatric epilepsy, generalized epilepsy with febrile
seizures plus (reviewed in Escayg and Goldin, 2010 and Egri and
Ruben, 2012), can also have a temperature-sensitive phenotype.
Our data provide a clear demonstration that a human disease
mutation in Munc18-1WT produces a defect in neuroexocytosis
that can be rescued at a lower, permissive temperature.
A number of Munc18-1 EIEE-linked mutations, including
C180Y, have been shown to have a tendency to form aggregates
in N2a cells (Saitsu et al., 2008) and PC12 cells (this study). How-
ever, the lack of association between protein aggregates and
neuronal cell death has led to the hypothesis that aggresome for-
mation could be a protectivemechanism and thatmost toxicity is
encodedwithin smaller oligomeric intermediates (Price andMor-
ris, 1999; Berke and Paulson, 2003). Despite the low apparent
abundance of Munc18-1C180Y aggregates in PC12 cells, we
found that the majority of the protein was insoluble, consistent
with the formation of smaller, morphologically undetectable,
detergent-insoluble oligomers.
Polyubiquitination can target proteins to different endpoints,
depending upon the biochemical nature of the ubiquitin chains
(Komander and Rape, 2012). K48-linked polyubiquitin is pre-
dominantly involved in targeting proteins for degradation by
the proteasome. Our demonstration that Munc18-1WT and
Munc18-1C180Y both label with K48-linked polyubiquitin is
clearly suggestive of a role for proteasomal degradation in the
normal regulation of Munc18-1 levels. This is in good agreement
with the recent finding (from a proteomics screen) thatMunc18-1
is ubiquitinated (Pridgeon et al., 2009). Further work will be
needed to identify the Munc18-1 ubiquitinated residue(s) and
the functional consequences of such ubiquitination. Interest-
ingly, the presence of distinct lower-molecular-weight (MW)
ubiquitinated bands in the Munc18-1WT and Munc18-1C180Y
immunoprecipitations suggests that Munc18-1 could also un-
dergo monoubiquitination (Figures 6C and 6E). Further studies
will be needed to determine whether this is indeed the case
and, if so, to address the functional relevance of such
modifications.
Together, our data demonstrate that Munc18-1-C180Y pro-
tein instability leads to a potentiation of Munc18-1 proteasomal
degradation and altered neuroexocytosis. Future studies will
be needed to demonstrate that such an alteration is directly or
indirectly linked to the generation of bursts suppressions due
to imbalanced neurotransmission in key areas of the brain. The
temperature sensitivity of the mutation also suggests that thera-
pies designed to temporarily alter the temperature of the brain
could potentially affect functional levels of Munc18-1C180Y.
The data in the current study are beginning to shed light on
some of the pathological features underlying the development of
EIEE in some patients. Determining whether other mutations in
Munc18-1 act in a similar manner is an important future
consideration.
EXPERIMENTAL PROCEDURES
Microscopy
PC12 cells or DKD-PC12 cells were transfected with Munc18-1 constructs us-
ing Lipofectamine LTX (Invitrogen) according to the manufacturer’s instruc-
tions and expressed for 24–48 hr prior to replating onto poly-D-lysine-coated
glass-bottomed MatTek dishes or glass coverslips. Cells were subsequently
treated as described in the Results section and processed for either fluores-
cencemicroscopy (confocal microscopy or TIRFmicroscopy) or for correlative
light and electronmicroscopy. Details are provided in the Supplemental Exper-
imental Procedures.
Immunoprecipitation and Western Blotting
PC12 cells or DKD-PC12 cells were transfected with Munc18-1 constructs as
described above. Cells were subsequently treated as described in the Results
section andwhole-cell lysates of Triton X-100 extracts analyzed by SDS-PAGE
and western blotting. To analyze solubility, equivalent amounts of protein were
solubilized in either 1% Triton X-100 (on ice; 60 min) or 1% SDS (20C; 5 min).
For immunoprecipitation, SDS-solubilized samples were subsequently diluted
in 10% Triton X-100 to give a final concentration of 1% Triton X-100 and 0.1%
SDS. GFP-tagged proteins were immunoprecipitated using GFP-Trap beads
as described previously (Martin et al., 2013). Details are provided in the Sup-
plemental Experimental Procedures.
NPY-hPLAP Release Assay
DKD-PC12 cells were cotransfected with NPY fused to the catalytic domain of
human placental alkaline phosphatase (NPY-hPLAP) and the indicated
Munc18-1 for 48 hr. Cells were washed and NPY-hPLAP release measured
as described previously using the Phospha-Light chemiluminescent reporter
gene assay system (Applied Biosystems), according to the manufacturer’s
instructions. The results are expressed as a percentage of total NPY-hPLAP.
Details are provided in the Supplemental Experimental Procedures.
In Vitro Analyses
Isothermal titration calorimetry was performed using bacterially expressed re-
combinant protein as described previously (Dea´k et al., 2009; Christie et al.,
2012). Full details are provided in the Supplemental Experimental Procedures.
The Leishmania tarentolae extracts (LTE) were prepared as described previ-
ously (Kovtun et al., 2011). LTE-generated proteins were used to measure
the interaction of Munc18-1WT and Munc18-1C180Y with Sx1a with a nano-
bead, ALPHAScreen assay. Single-molecule spectroscopy was performed
as described previously (Sierecki et al., 2014; Gambin et al., 2014) following
incubation of Munc18-1 or Munc18-1C180Y at different temperatures
(30C–40C) for 15 or 30 min. Full details are provided in the Supplemental
Experimental Procedures.
Statistical Analyses
Unless specified, statistical analysis was performed with an unpaired Stu-
dent’s t test assuming equal variance. Results shown are all mean ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures
and three figures and can be found with this article online at http://dx.doi.
org/10.1016/j.celrep.2014.08.059.
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